2m 2m 2m 2m 2m 2m 2m
MediWound (MDWD)
NASDAQ
$13.59-$0.17 (-1.26%)
Price as of Jun 03, 2026 5:36 PM EDT- $184.2MMarket Cap
- -36.27%1-Year Change
- BiotechnologyIndustry
MediWound (MDWD)
$13.59-$0.17 (-1.26%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 17.0M -16.14% | 20.2M +8.22% | 18.7M -29.48% | 26.5M +11.50% | |
Cost of Revenue | 13.7M -22.08% | 17.6M +16.42% | 15.1M +13.33% | 13.3M -11.08% | |
Gross Profit | 3.3M +23.54% | 2.6M -26.38% | 3.6M -72.82% | 13.2M +50.10% | |
Sales and Marketing Expense | 8.4M +3.00% | 8.2M +21.19% | 6.8M -2.20% | 6.9M +9.01% | |
Research and Development Expense | -14.3M +61.30% | -8.9M +18.90% | -7.5M -26.66% | -10.2M -0.73% | |
Depreciation and Amortization Expense | 1.9M +25.42% | 1.5M +13.81% | 1.3M +2.44% | 1.3M +2.75% | |
Total Operating Expenses | 8.4M +3.00% | 8.2M +21.19% | 6.8M -2.20% | 6.9M +9.01% | |
Operating Profit | -25.3M +30.24% | -19.4M +26.88% | -15.3M +83.22% | -8.3M -25.63% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 211,000 +1,272.22% | -18,000 -108.53% | 211,000 N/A | N/A N/A | |
Income before Taxes | -23.9M -20.99% | -30.2M +350.03% | -6.7M -65.73% | -19.6M +44.63% | |
Income Taxes | 169,000 +177.05% | 61,000 -67.03% | 185,000 +137.18% | 78,000 +188.89% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -23.9M -20.99% | -30.2M +350.03% | -6.7M -65.73% | -19.6M +44.63% | |
Net Income from Continuing Operations Applicable to Common | -23.9M -20.99% | -30.2M +350.03% | -6.7M -65.73% | -19.6M +44.63% | |
Basic EPS and Net Income | -2.10 -30.69% | -3.03 +304.00% | -0.75 -80.92% | -3.93 N/A | |
Diluted EPS and Net Income | -2.10 -30.69% | -3.03 +304.00% | -0.75 -80.92% | -3.93 N/A | |
Basic Weighted Average Shares | 11.4M +14.23% | 10.0M +10.50% | 9.0M N/A | N/A N/A | |
Diluted Weighted Average Shares | 11.4M +14.23% | 10.0M +10.50% | 9.0M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.8M -47.58% | 9.2M -22.85% | 11.9M -64.99% | 33.9M +206.85% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.8M -47.58% | 9.2M -22.85% | 11.9M -64.99% | 33.9M +206.85% | |
Total Current Assets | 60.0M +14.96% | 52.2M +4.97% | 49.7M +8.41% | 45.8M +206.58% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 18.6M +31.90% | 14.1M +53.14% | 9.2M +290.03% | 2.4M -4.52% | |
Total Long-Term Assets | 26.3M +23.24% | 21.3M +27.25% | 16.8M +301.44% | 4.2M -12.85% | |
Total Assets | 86.3M +17.36% | 73.5M +10.59% | 66.5M +32.88% | 50.0M +153.32% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 25.7M -3.14% | 26.5M +145.09% | 10.8M -10.18% | 12.1M +12.46% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 16.9M +7.04% | 15.8M -34.25% | 24.0M -11.13% | 27.0M +98.79% | |
Total Liabilities | 42.6M +0.66% | 42.3M +21.45% | 34.9M -10.84% | 39.1M +60.74% | |
Retained Earnings | -228.9M +11.65% | -205.0M +17.29% | -174.8M +4.00% | -168.1M +13.20% | |
Total Stockholders Equity | 43.6M +40.06% | 31.2M -1.40% | 31.6M +189.49% | 10.9M +338.19% | |
Total Shares Outstanding | 12.8M +18.92% | 10.8M +17.04% | 9.2M +27.37% | 7.2M -73.45% | |
Cash Flow | |||||
Cash from Operating Activities | -16.1M +18.33% | -13.6M +30.19% | -10.5M -11.95% | -11.9M +33.30% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -17.9M +113.77% | -8.4M -75.53% | -34.3M +7,035.34% | -481,000 -113.56% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 29.6M +52.73% | 19.4M -15.37% | 22.9M N/A | N/A N/A | |
Financials Ratio | |||||
Gross Margin | 19.19% +47.31% | 13.03% -31.98% | 19.15% -61.46% | 49.69% +34.61% | |
Operating Margin | -148.98% +55.30% | -95.94% +17.24% | -81.83% +159.80% | -31.50% -33.30% | |
Return on Assets | -29.90% -30.78% | -43.19% +274.53% | -11.53% -79.48% | -56.19% +5.35% | |
Return on Equity | -63.86% -33.71% | -96.33% +204.88% | -31.60% -94.90% | -619.05% -38.56% | |
Revenue Growth | -16.14% -296.30% | 8.22% +127.89% | -29.48% -356.29% | 11.50% +25.15% | |
Current Ratio | 2.33 +18.68% | 1.97 -57.17% | 4.59 +20.71% | 3.80 +172.62% | |
Cash Ratio | 0.19 -45.87% | 0.34 -68.53% | 1.10 -61.02% | 2.81 +172.85% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow